| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Chief Medical Officer | Class A Common Stock | 225K | $1.39M | $6.18 | Nov 15, 2024 | Direct |
| RECURSION PHARMACEUTICALS, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 381K | Nov 15, 2024 | Direct | ||
| Codiak BioSciences, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 190K | Jan 24, 2023 | Direct | ||
| Prelude Therapeutics Inc | Chief Medical Officer | Employee Stock Option (Right to Buy) | 138K | Oct 5, 2021 | Direct | ||
| Prelude Therapeutics Inc | Chief Medical Officer | Common Stock | 0 | $3.77 | Oct 5, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Nov 15, 2024 | 1 | -$25.9K | 4 | Nov 19, 2024 | Chief Medical Officer |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Aug 15, 2024 | 1 | -$94.6K | 4 | Aug 19, 2024 | Chief Medical Officer |
| RXRX | RECURSION PHARMACEUTICALS, INC. | May 15, 2024 | 1 | -$8.68K | 4 | May 17, 2024 | Chief Medical Officer |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Feb 9, 2024 | 4 | -$19.1K | 4 | Feb 13, 2024 | Chief Medical Officer |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Jun 1, 2023 | 2 | $0 | 4 | Jun 7, 2023 | Chief Medical Officer |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Jun 1, 2023 | 0 | $0 | 3 | Jun 7, 2023 | Chief Medical Officer |
| CDAKQ | Codiak BioSciences, Inc. | Jan 24, 2023 | 1 | $0 | 4 | Jan 26, 2023 | Chief Medical Officer |
| CDAKQ | Codiak BioSciences, Inc. | Sep 16, 2022 | 1 | $0 | 4 | Sep 20, 2022 | Chief Medical Officer |
| CDAKQ | Codiak BioSciences, Inc. | May 2, 2022 | 2 | $0 | 4 | May 4, 2022 | Chief Medical Officer |
| CDAKQ | Codiak BioSciences, Inc. | May 2, 2022 | 0 | $0 | 3 | May 4, 2022 | Chief Medical Officer |
| PRLD | Prelude Therapeutics Inc | Oct 5, 2021 | 5 | -$436K | 4 | Oct 6, 2021 | Chief Medical Officer |
| PRLD | Prelude Therapeutics Inc | Sep 7, 2021 | 5 | -$522K | 4 | Sep 9, 2021 | Chief Medical Officer |
| PRLD | Prelude Therapeutics Inc | Aug 5, 2021 | 6 | -$438K | 4 | Aug 9, 2021 | Chief Medical Officer |
| PRLD | Prelude Therapeutics Inc | Jul 20, 2021 | 1 | $0 | 4 | Jul 22, 2021 | Chief Medical Officer |
| PRLD | Prelude Therapeutics Inc | Jul 6, 2021 | 5 | -$384K | 4 | Jul 8, 2021 | Chief Medical Officer |
| PRLD | Prelude Therapeutics Inc | Jun 7, 2021 | 5 | -$458K | 4 | Jun 9, 2021 | Chief Medical Officer |
| PRLD | Prelude Therapeutics Inc | May 5, 2021 | 5 | -$574K | 4 | May 10, 2021 | Chief Medical Officer |